Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Wanying Li

Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement

SLAS Discovery

English

Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results From Two Randomized, Controlled Phase 2b Trials

Rheumatology and Therapy

2020

English

Related publications

Ono-4059 (Gs-4059), a Next Generation BTK Inhibitor, Monotherapy in Patients With B-Cell Malignancies in the Japanese Phase 1, Dose-Escalation Study

Hematological Oncology

English

Bruton Tyrosine Kinase Inhibitor ONO/GS-4059: From Bench to Bedside

Oncotarget

Oncology

2016

English

Homogeneous Assay for Target Engagement Utilizing Bioluminescent Thermal Shift

ACS Medicinal Chemistry Letters

English

Multiplexing of Receptor Occupancy Measurements for Pharmacodynamic Biomarker Assessment of Biopharmaceuticals

Cytometry Part B - Clinical Cytometry

English

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Journal of Biomolecular Screening

English

Faculty Target-Based Engagement Assessment Statistical Model for Enhancing Performance and Education Quality

IAFOR Journal of Education

Education

Public Administration

2019

English

Cell Line‐based Assessment of BTK Inhibitors

British Journal of Pharmacology

Pharmacology

2020

English

Flow Cytometry Assessment of Intracellular BTK Expression

Cytometry Part B - Clinical Cytometry

English

Pharmacodynamic Target Attainment for Various Ceftazidime Dosing Schemes in High-Flux Hemodialysis

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2013

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Wanying Li

Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement

Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results From Two Randomized, Controlled Phase 2b Trials

Related publications

Ono-4059 (Gs-4059), a Next Generation BTK Inhibitor, Monotherapy in Patients With B-Cell Malignancies in the Japanese Phase 1, Dose-Escalation Study

Bruton Tyrosine Kinase Inhibitor ONO/GS-4059: From Bench to Bedside

Homogeneous Assay for Target Engagement Utilizing Bioluminescent Thermal Shift

Multiplexing of Receptor Occupancy Measurements for Pharmacodynamic Biomarker Assessment of Biopharmaceuticals

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Faculty Target-Based Engagement Assessment Statistical Model for Enhancing Performance and Education Quality

Cell Line‐based Assessment of BTK Inhibitors

Flow Cytometry Assessment of Intracellular BTK Expression

Pharmacodynamic Target Attainment for Various Ceftazidime Dosing Schemes in High-Flux Hemodialysis